Charles Schwab Investment Management Inc United Therapeutics Corp Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 369,955 shares of UTHR stock, worth $135 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
369,955
Previous 387,793
4.6%
Holding current value
$135 Million
Previous $124 Million
7.32%
% of portfolio
0.03%
Previous 0.02%
Shares
29 transactions
Others Institutions Holding UTHR
# of Institutions
671Shares Held
42.3MCall Options Held
194KPut Options Held
295K-
Black Rock Inc. New York, NY5.47MShares$1.99 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.41MShares$1.6 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.17MShares$1.15 Billion0.2% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$1.04 Billion15.42% of portfolio
-
State Street Corp Boston, MA2.24MShares$814 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $16.6B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...